We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NOAH:NYSENoah Holdings Limited Analysis

Data as of 2026-05-19 - not real-time

$10.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Noah Holdings trades at a trailing P/E of 8.7, well below the asset‑management industry average of 16.7, and offers a 5.6% dividend yield with a payout ratio just above 50%, suggesting attractive income potential. Strong balance‑sheet metrics—$5.0 bn in cash versus $0.1 bn of debt—and solid operating margins (gross 53%, operating 35%) provide a cushion for continued dividend payments and modest growth. However, technical signals are mixed: the 20‑day SMA (10.52) sits just below the current price (10.2), the MACD is bearish, RSI hovers around 41, and the stock is testing a support near $10.02 while facing resistance around $11.05, indicating short‑term downside pressure. Market sentiment is extremely positive (Fear & Greed index 89) and the DCF‑derived fair value suggests ~32% upside, yet volatility remains high at ~27% and beta near 1, underscoring price swings. Overall, the company appears fundamentally undervalued with a sustainable dividend, but investors should watch technical weakness and broader macro‑risk in the Chinese wealth‑management space.
The recent shareholder communication and the proposal to distribute 100% of 2025 earnings as a dividend reinforce management’s confidence in cash generation. Coupled with a dual‑primary listing and insider ownership, these factors support a longer‑term bullish thesis, provided the firm can successfully transition to a recurring‑revenue model and navigate regulatory headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and RSI near neutral suggest limited upside in the near term
  • Price is near the identified support level of $10.02
  • High dividend yield provides cushion while waiting for technical recovery

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervaluation relative to industry P/E and DCF upside of ~32%
  • Strong cash position and low leverage support earnings growth
  • Sustainable dividend with payout ratio ~52% enhances total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic shift to asset‑management‑driven recurring revenue improves margin stability
  • Insider ownership aligns management interests with shareholders
  • Long‑term demographic trends in China’s high‑net‑worth segment offer growth tailwinds

Key Metrics & Analysis

Financial Health

Revenue Growth12.50%
Profit Margin21.41%
P/E Ratio8.7
ROE5.57%
ROA4.13%
Debt/Equity1.03
P/B Ratio0.5
Op. Cash Flow$976.6M
Free Cash Flow$625.9M
Industry P/E16.7

Technical Analysis

TrendBearish
RSI40.9
Support$10.02
Resistance$11.05
MA 20$10.52
MA 50$10.59
MA 200$11.16
MACDBearish
VolumeStable
Fear & Greed Index89.27

Valuation

Fair Value$283.95
Target Price$13.46
Upside/Downside32.01%
GradeUndervalued
TypeValue
Dividend Yield5.63%

Risk Assessment

Beta1.04
Volatility26.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.